Catalyst Wire Dossier Catalyst Wire Dossier

FK949E

· Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for FK949E, covering 2017-02-08 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder [Phase 1]

See pricing